About Reditus Laboratories: Revolutionizing Laboratory Pathology for Enhanced Healthcare
Reditus Laboratories, founded in June 2019 in Pekin, IL, initially aimed to provide laboratory pathology support for podiatrist patients. However, the company's vision quickly expanded, leading them to specialize in various pathology tests on clinical specimens. Their mission is to assist medical professionals in diagnosing, treating, and preventing diseases accurately and efficiently.
Empowering the Fight Against Covid-19
In December 2019, Reditus made a game-changing acquisition by obtaining its first real-time reverse transcriptase polymerase chain reaction (RT-PCR) machine. This cutting-edge technology would later prove invaluable for mass testing the American population during the Covid-19 pandemic. The acquisition granted Reditus Labs access to the most sensitive mRNA detection and quantitation technique.
Expansion for Greater Impact
Reditus experienced significant growth in physical capacity when its laboratory expanded from 2,500 sq. ft. to over 23,000 sq. ft. in March 2021. With this expansion, the company commenced offering anatomic pathology services to diagnose soft tissue and wound infections for various healthcare providers.
Comprehensive Covid Testing Services
Reditus quickly emerged as a national leader in Covid testing services, having processed over 3.3 million tests and counting. Their laboratory offers turnkey solutions to schools, universities, and private industries. During the worldwide pandemic, Reditus played a vital role by providing on-site training for Covid testing at educational institutions, along with the necessary staff, testing supplies, and kits. This support helped keep schools open, ensuring the health and well-being of children.
Unparalleled Testing Capacity
With the ability to run 100,000 tests daily, Reditus Laboratories also provided testing services for government organizations using its ThermoFisher EUA PCR High-throughput testing platform. The company supplied complete test collection kits, including sterile nasal swabs, transport tubes, and viral media.
Efficiency and Impact
The remarkable efficiency with which Reditus operated during its early years is a testament to the exceptional leadership that founded the company. By supplying protective gear like glasses, gowns, and masks and accurately testing a vast number of individuals at the local and national levels, Reditus significantly contributed to reducing the spread of Covid-19.
Advancing Diagnostic Testing in Various Fields
Even before the nation's focus on the Covid pandemic, Reditus was already a renowned testing lab for podiatry. The company had embarked on an expansion into urology and histology testing. Histology tests play a crucial role in diagnosing abnormalities in human cells or tissue, enabling the detection of microorganisms responsible for infections, diseases, and even cancer.
State-of-the-Art Equipment for Precise Diagnosis and Treatment
Reditus utilizes state-of-the-art equipment and follows clinical laboratory procedures to diagnose diseases and injuries accurately. Whether it's analyzing skin biopsies, wound samples, or wart specimens, their advanced techniques provide valuable insights into effective treatment methods.
Dedicated to Serving Patients and Healthcare Providers
Reditus was initially launched to provide pathology services to patients and clinicians. Their diagnostic testing impacts every phase of patient care, from initial diagnosis to chronic disease management and curative solutions for acute injuries or illnesses. The company is committed to providing accurate laboratory testing that is easily accessible with a fast turnaround time.
Partnering with Institutions and Organizations
In addition to serving referred and walk-in patients, Reditus Laboratories Labs has become a national leader in Covid laboratory testing for universities and local school districts. They offer a comprehensive turnkey solution that includes personal protective equipment, on-site testing staff, and a web-based portal for private access to test results. Recognizing corporate and government entities' unique challenges and requirements, Reditus Labs maintains partnerships for on-site employee testing. The company offers customized scope services and works directly with HR departments to implement effective infectious disease testing and surveillance programs. Their comprehensive solution, "Reditus FluV19," facilitates the detection of Covid, Influenza A, and Influenza B.
Ensuring Public Safety through Mass Testing
When mass testing of the general public became necessary, Reditus promptly organized and deployed concierge events at public locations. These events offered drive-up, walk-in, or by-appointment testing services for the general population. With the capacity to run over 40,000 Covid-19 tests per day and a specificity and sensitivity greater than 98.9%, Reditus played a significant role in helping the community stay safe and return to normalcy.
Meet the Visionary Leaders of Reditus Laboratories
The company is led by its founder and CEO, Dr. Aaron Rossi, MD. Dr. Rossi graduated from Elmhurst College in 2006 and obtained his medical degree from the University of Sint Eustatius School of Medicine in 2012. His journey across the healthcare continuum has equipped him with a deep understanding of various capacities within the industry. Driven by his passion for private medical practice management, Dr. Rossi's proven model has fueled his entrepreneurial ventures.
As the President of Reditus, Lawrence J. Rossi, Jr., MD, brings over 40 years of medical patient service experience to the company. His distinguished career spans various disciplines, including pediatrics, critical care, anesthesiology, and pain management. Dr. Lawrence Rossi's invaluable healthcare operations experience stems from his tenure at Hopedale Medical Complex in Hopedale, Illinois. He completed his pediatric residency at the University of Illinois-Peoria School of Medicine and holds board certifications from the American Academy of Pediatrics-FAAP, the American Board of Anesthesiology, and the American Board of Medical Acupuncture (DABMA).
Leading Operations and Excellence
Michelle Anderson, the Director of Operations at Reditus Laboratories, oversees the performance and development of diagnostic tests submitted to the Molecular Laboratory. She is a certified medical laboratory technician accredited by the American Society of Clinical Pathology. Michelle Anderson's extensive training in analyzing diseased tissue and fluids was acquired during her previous role as a hematology department technician at Unity Point Health in Peoria, Illinois. She continued her education at the University of Cincinnati while completing her degree from Illinois Central College in 1994.
Guiding Clinical Support for Optimal Patient Care
Dr. Jerome Anderson, D.O., serves as the Medical Director of Reditus. Board-certified by the American Board of Pathology, he coordinates teams and oversees clinical support for patient care. Dr. Anderson obtained his Doctor of Osteopathic Medicine degree from the Chicago College of Osteopathic Medicine in 1986. After completing his pathology residency during ten years of active duty in the United States Air Force, he served as the Medical Director at McDonough District Hospital in Macomb, Illinois, making significant contributions to patient care.
With a team led by these experienced and visionary individuals, Reditus continues to revolutionize laboratory pathology, empower healthcare professionals, and ensure the well-being of patients and communities well-being.
Empowering the Fight Against Covid-19
In December 2019, Reditus made a game-changing acquisition by obtaining its first real-time reverse transcriptase polymerase chain reaction (RT-PCR) machine. This cutting-edge technology would later prove invaluable for mass testing the American population during the Covid-19 pandemic. The acquisition granted Reditus Labs access to the most sensitive mRNA detection and quantitation technique.
Expansion for Greater Impact
Reditus experienced significant growth in physical capacity when its laboratory expanded from 2,500 sq. ft. to over 23,000 sq. ft. in March 2021. With this expansion, the company commenced offering anatomic pathology services to diagnose soft tissue and wound infections for various healthcare providers.
Comprehensive Covid Testing Services
Reditus quickly emerged as a national leader in Covid testing services, having processed over 3.3 million tests and counting. Their laboratory offers turnkey solutions to schools, universities, and private industries. During the worldwide pandemic, Reditus played a vital role by providing on-site training for Covid testing at educational institutions, along with the necessary staff, testing supplies, and kits. This support helped keep schools open, ensuring the health and well-being of children.
Unparalleled Testing Capacity
With the ability to run 100,000 tests daily, Reditus Laboratories also provided testing services for government organizations using its ThermoFisher EUA PCR High-throughput testing platform. The company supplied complete test collection kits, including sterile nasal swabs, transport tubes, and viral media.
Efficiency and Impact
The remarkable efficiency with which Reditus operated during its early years is a testament to the exceptional leadership that founded the company. By supplying protective gear like glasses, gowns, and masks and accurately testing a vast number of individuals at the local and national levels, Reditus significantly contributed to reducing the spread of Covid-19.
Advancing Diagnostic Testing in Various Fields
Even before the nation's focus on the Covid pandemic, Reditus was already a renowned testing lab for podiatry. The company had embarked on an expansion into urology and histology testing. Histology tests play a crucial role in diagnosing abnormalities in human cells or tissue, enabling the detection of microorganisms responsible for infections, diseases, and even cancer.
State-of-the-Art Equipment for Precise Diagnosis and Treatment
Reditus utilizes state-of-the-art equipment and follows clinical laboratory procedures to diagnose diseases and injuries accurately. Whether it's analyzing skin biopsies, wound samples, or wart specimens, their advanced techniques provide valuable insights into effective treatment methods.
Dedicated to Serving Patients and Healthcare Providers
Reditus was initially launched to provide pathology services to patients and clinicians. Their diagnostic testing impacts every phase of patient care, from initial diagnosis to chronic disease management and curative solutions for acute injuries or illnesses. The company is committed to providing accurate laboratory testing that is easily accessible with a fast turnaround time.
Partnering with Institutions and Organizations
In addition to serving referred and walk-in patients, Reditus Laboratories Labs has become a national leader in Covid laboratory testing for universities and local school districts. They offer a comprehensive turnkey solution that includes personal protective equipment, on-site testing staff, and a web-based portal for private access to test results. Recognizing corporate and government entities' unique challenges and requirements, Reditus Labs maintains partnerships for on-site employee testing. The company offers customized scope services and works directly with HR departments to implement effective infectious disease testing and surveillance programs. Their comprehensive solution, "Reditus FluV19," facilitates the detection of Covid, Influenza A, and Influenza B.
Ensuring Public Safety through Mass Testing
When mass testing of the general public became necessary, Reditus promptly organized and deployed concierge events at public locations. These events offered drive-up, walk-in, or by-appointment testing services for the general population. With the capacity to run over 40,000 Covid-19 tests per day and a specificity and sensitivity greater than 98.9%, Reditus played a significant role in helping the community stay safe and return to normalcy.
Meet the Visionary Leaders of Reditus Laboratories
The company is led by its founder and CEO, Dr. Aaron Rossi, MD. Dr. Rossi graduated from Elmhurst College in 2006 and obtained his medical degree from the University of Sint Eustatius School of Medicine in 2012. His journey across the healthcare continuum has equipped him with a deep understanding of various capacities within the industry. Driven by his passion for private medical practice management, Dr. Rossi's proven model has fueled his entrepreneurial ventures.
As the President of Reditus, Lawrence J. Rossi, Jr., MD, brings over 40 years of medical patient service experience to the company. His distinguished career spans various disciplines, including pediatrics, critical care, anesthesiology, and pain management. Dr. Lawrence Rossi's invaluable healthcare operations experience stems from his tenure at Hopedale Medical Complex in Hopedale, Illinois. He completed his pediatric residency at the University of Illinois-Peoria School of Medicine and holds board certifications from the American Academy of Pediatrics-FAAP, the American Board of Anesthesiology, and the American Board of Medical Acupuncture (DABMA).
Leading Operations and Excellence
Michelle Anderson, the Director of Operations at Reditus Laboratories, oversees the performance and development of diagnostic tests submitted to the Molecular Laboratory. She is a certified medical laboratory technician accredited by the American Society of Clinical Pathology. Michelle Anderson's extensive training in analyzing diseased tissue and fluids was acquired during her previous role as a hematology department technician at Unity Point Health in Peoria, Illinois. She continued her education at the University of Cincinnati while completing her degree from Illinois Central College in 1994.
Guiding Clinical Support for Optimal Patient Care
Dr. Jerome Anderson, D.O., serves as the Medical Director of Reditus. Board-certified by the American Board of Pathology, he coordinates teams and oversees clinical support for patient care. Dr. Anderson obtained his Doctor of Osteopathic Medicine degree from the Chicago College of Osteopathic Medicine in 1986. After completing his pathology residency during ten years of active duty in the United States Air Force, he served as the Medical Director at McDonough District Hospital in Macomb, Illinois, making significant contributions to patient care.
With a team led by these experienced and visionary individuals, Reditus continues to revolutionize laboratory pathology, empower healthcare professionals, and ensure the well-being of patients and communities well-being.